CLINICAL_TRIALS ClinicalTrials.gov record update

Evaluation of the Safety, Tolerability, Efficacy and Activity of AMX0035, a Fixed Combination of Phenylbutyrate (PB) and Tauroursodeoxycholic Acid (TUDCA), for the Treatment of ALS

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03127514
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:31.385900+00:00
Published At: 2021-08-11T00:00:00+00:00
Record Updated At: 2024-05-16
Results Posted At: 2021-08-11
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Amyotrophic Lateral Sclerosis", "Motor Neuron Disease", "Neuromuscular Diseases", "Neurodegenerative Diseases", "Spinal Cord Diseases", "TDP-43 Proteinopathies", "Nervous System Diseases", "Central Nervous System Diseases"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-05-16"
protocolSection.identificationModule.nctId: "NCT03127514"
protocolSection.identificationModule.officialTitle: "Evaluation of the Safety, Tolerability, Efficacy and Activity of AMX0035, a Fixed Combination of Phenylbutyrate (PB) and Tauroursodeoxycholic Acid (TUDCA), for the Treatment of ALS"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2021-08-11"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.